Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
VIRALEZE SPL7013 virucidal (>99.99%) against Delta variant 2021-07-27 19:53
iXensor Levels Up PixoTest Covid-19 Ag Test With The Launch Of PixoHealth Data Management Platform As The Security Solution For The New Normalcy 2021-07-27 19:32
LifeSignals receives FDA 510 (k) Approval for LifeSignals LX1550 Multiparameter Remote Monitoring Platform 2021-07-27 19:00
New Mountain Capital to Acquire Flexan 2021-07-27 18:00
MicroPort® Cardiac Rhythm Management Business Announces US$150 Million Series C Investment 2021-07-27 15:42
Cytiva and Pall Corporation investing 1.5 billion USD over two years to meet growing demand for biotechnology solutions 2021-07-27 14:05
CathWorks FFRangio™ System Receives National Reimbursement Approval in Japan 2021-07-26 22:00
ORTHO OPTIX™ Reader Completes Transfusion Medicine Portfolio, Now Available in Canada 2021-07-26 21:00
Beckman Coulter to Distribute BNP Cardiac Assay to Customers 2021-07-26 20:56
PharmAbcine to Present at H.C Wainwright Ophthalmology Virtual Conference 2021-07-26 20:00
HBM Presents Phase I Data on Next-Generation Anti-CTLA-4 Antibody at ESMO Congress 2021 2021-07-26 19:11
Collaborative Drug Discovery (CDD) Launches BioHarmony 2021-07-26 18:57
100-day countdown begins for the fourth CIIE 2021-07-26 18:03
WuXi Biologics Received Commercial Manufacturing License from German Health Authorities for its German Drug Product Facility 2021-07-26 18:00
Hummingbird Bioscience Appoints Renowned Scientist and Medical Oncologist Dr. Thomas J. Lynch to its Board of Directors 2021-07-26 17:00
Global Medical Imaging & Informatics Market Thrives with AI and Cloud as Healthcare Sector Focuses on Quadruple Aim 2021-07-26 16:02
Laekna Therapeutics will present two clinical study results in ESMO 2021 2021-07-26 13:26
Manulife Hong Kong joins hands with Hong Kong Baptist Hospital to strengthen health solutions offering 2021-07-26 12:25
Antengene and Its Partners Publish Preclinical Data Demonstrating the Encouraging Activity of Selinexor in the Prevention and Treatment of SARS-CoV-2 Infections 2021-07-26 08:44
Innovent Announces the First Patient Dosed in the Phase 1 Study of IBI321 (Anti-PD-1/TIGIT Bispecific Antibody) in Patients with Advanced Malignant Tumors 2021-07-26 08:00
1 367 368 369 370 371 895